Skip to main content
. 2015 Jul 9;113(5):827–832. doi: 10.1038/bjc.2015.249

Table 2. Breast cancer characteristics (a total of 2833 invasive breast cancer) by diabetes status identified from CMS data.

  No diabetes (2534 patients) Diabetes (299 patients) P-valuea
Stage     0.001
Local 1976 (78.0) 216 (72.2)  
Regional 534 (21.1) >=11 (∼)  
Advanced 24 (1.0) <11 (∼)  
Tumour size, mm     0.13
≤5 319 (12.6) 28 (9.4)  
>5–10 691 (27.3) 73 (24.4)  
>10–20 822 (32.4) 100 (33.4)  
≥20 702 (27.7) 98 (32.8)  
Positive lymph nodes     0.17
No 1977 (78.0) 219 (73.2)  
Yes 513 (20.2) 73 (24.4)  
Grade     0.09
Well differentiated 682 (26.9) 71 (23.8)  
Moderately differentiated 1014 (40.0) 144 (48.2)  
Poorly differentiated 567 (22.4) 55 (18.4)  
Anaplastic 55 (2.2) <11 (∼)  
Missing 216 (8.5) >11 (∼)  
OEstrogen receptor status     0.75
Positive 2042 (80.6) 239 (79.9)  
Negative 346 (13.7) 40 (13.4)  
Borderline <11 (∼) <11 (∼)  
Unknown/not done/missing >11 (∼) >11 (∼)  
Progesterone receptor status     0.66
Positive 1736 (68.5) 200 (66.9)  
Negative 640 (25.3) 75 (25.1)  
Borderline 12 (0.5) <11 (∼)  
Unknown/not done/missing 146 (5.8) >11 (∼)  
HER2     0.02
Positive 300 (11.8) 24 (8.0)  
Negative 1686 (66.5) 229 (76.6)  
Borderline 20 (0.8) <11 (∼)  
Unknown/not done/missing 528 (20.8) >11 (∼)  
Mammography interval     0.02
<1 year 1316 (51.9) 132 (44.2)  
1 to <2 years 387 (15.3) 48 (16.1)  
2 to <5 years 428 (16.9) 71 (23.8)  
5 or more years or never 403 (15.9) 48 (16.1)  
Surgery     0.10
No surgery 118 (4.7) 18 (6.0)  
Breast conserving surgery (BCS) 1648 (65.0) 176 (58.9)  
Mastectomy 768 (30.3) 105 (35.1)  
Chemotherapy (yes) 565 (22.3) 72 (24.1) 0.48
Radiation (yes) 1486 (58.6) 152 (50.8) 0.01

(∼) The cell sizes were suppressed for confidentiality reasons per the Medicare data usage agreement.

a

χ2-test included missing category.